Francisco Vera-Badillo

9.8k total citations · 2 hit papers
76 papers, 5.5k citations indexed

About

Francisco Vera-Badillo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Francisco Vera-Badillo has authored 76 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 36 papers in Oncology and 27 papers in Cancer Research. Recurrent topics in Francisco Vera-Badillo's work include Prostate Cancer Treatment and Research (26 papers), Cancer, Lipids, and Metabolism (12 papers) and Renal cell carcinoma treatment (9 papers). Francisco Vera-Badillo is often cited by papers focused on Prostate Cancer Treatment and Research (26 papers), Cancer, Lipids, and Metabolism (12 papers) and Renal cell carcinoma treatment (9 papers). Francisco Vera-Badillo collaborates with scholars based in Canada, Spain and Slovenia. Francisco Vera-Badillo's co-authors include Eitan Amir, Arnoud J. Templeton, Ian F. Tannock, Alberto Ocaña, Boštjan Šeruga, Mairéad G. McNamara, Jennifer J. Knox, Raya Leibowitz‐Amit, Priya Aneja and Guru Sonpavde and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Francisco Vera-Badillo

73 papers receiving 5.4k citations

Hit Papers

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Soli... 2014 2026 2018 2022 2014 2014 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
    2014 2.3k citations Arnoud J. Templeton, Mairéad G. McNamara et al. profile →
  2. Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
    2014 546 citations Arnoud J. Templeton, Olga Ace et al. Cancer Epidemiology Biomarkers & Prevention profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco Vera-Badillo Canada 27 3.4k 1.6k 1.2k 902 754 76 5.5k
Esther Bastiaannet Netherlands 45 4.5k 1.3× 1.6k 1.0× 1.8k 1.4× 1.6k 1.7× 847 1.1× 263 6.9k
Heather Lin United States 40 2.2k 0.6× 1.6k 1.0× 1.0k 0.8× 949 1.1× 1.3k 1.7× 173 4.9k
Umberto Basso Italy 35 2.1k 0.6× 1.7k 1.0× 736 0.6× 775 0.9× 1.0k 1.3× 236 4.7k
Gloria Broadwater United States 42 3.1k 0.9× 1.0k 0.6× 1.8k 1.5× 776 0.9× 1.2k 1.6× 182 6.2k
Arnoud J. Templeton Switzerland 40 5.6k 1.7× 2.6k 1.6× 1.9k 1.5× 1.5k 1.7× 1.1k 1.5× 152 8.6k
Joseph Kim United States 40 2.5k 0.7× 1.0k 0.6× 888 0.7× 1.2k 1.4× 1.1k 1.5× 175 4.8k
Jyoti D. Patel United States 38 3.9k 1.2× 3.4k 2.1× 832 0.7× 493 0.5× 1.4k 1.9× 230 6.1k
Ben Tran Australia 14 2.7k 0.8× 994 0.6× 1.1k 0.9× 679 0.8× 405 0.5× 61 4.0k
Kan Yonemori Japan 38 3.8k 1.1× 1.9k 1.2× 898 0.7× 508 0.6× 1.4k 1.8× 392 6.2k
Sylvie Chabaud France 35 1.6k 0.5× 2.3k 1.4× 600 0.5× 1.1k 1.2× 782 1.0× 191 5.6k

Countries citing papers authored by Francisco Vera-Badillo

Since Specialization
Citations

This map shows the geographic impact of Francisco Vera-Badillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Vera-Badillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Vera-Badillo more than expected).

Fields of papers citing papers by Francisco Vera-Badillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Vera-Badillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Vera-Badillo. The network helps show where Francisco Vera-Badillo may publish in the future.

Co-authorship network of co-authors of Francisco Vera-Badillo

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Vera-Badillo. A scholar is included among the top collaborators of Francisco Vera-Badillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Vera-Badillo. Francisco Vera-Badillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seung, Soo Jin, et al.. (2023). A real-world retrospective analysis of the management of metastatic castrate-resistant prostate cancer in Ontario, Canada from 2010 – 2018. Urologic Oncology Seminars and Original Investigations. 41(3). 146.e13–146.e22. 1 indexed citations
2.
Sandhu, Shahneen, Geoffrey Gotto, Francisco Vera-Badillo, et al.. (2023). 1835P A prospective study to determine the prevalence of DNA repair defects in patients (pts) with advanced prostate cancer (PC). Annals of Oncology. 34. S993–S993. 2 indexed citations
3.
Simmons, Christine, Rebecca Deyell, Andrea J. MacNeill, et al.. (2021). Canadian consensus onTRK‐inhibitortherapy forNTRKfusion‐positive sarcoma. International Journal of Cancer. 149(9). 1691–1704. 4 indexed citations
4.
Khalid, Sidra, Christopher M. Booth, Ignacio Durán, et al.. (2020). Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis. European Urology Open Science. 21. 61–68. 2 indexed citations
5.
Vera-Badillo, Francisco, et al.. (2020). Discussion of Treatment Options for Metastatic Hormone Sensitive Prostate Cancer Patients. Frontiers in Oncology. 10. 587981–587981. 4 indexed citations
6.
Amir, Eitan, Markus Kuksis, David Hernández‐Barajas, et al.. (2019). PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis. Cancer Treatment Reviews. 76. 51–56. 29 indexed citations
7.
Siemens, D. Robert, Melanie Jaeger, Xuejiao Wei, Francisco Vera-Badillo, & Christopher M. Booth. (2017). Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study. World Journal of Urology. 35(9). 1435–1442. 21 indexed citations
8.
Rodríguez‐Romo, Laura, David Hernández‐Barajas, Juan Francisco González-Guerrero, et al.. (2017). Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis. Cancer Treatment Reviews. 62. 1–8. 75 indexed citations
9.
Vera-Badillo, Francisco, Monika K. Krzyzanowska, Shabbir M.H. Alibhai, et al.. (2016). Honorary and ghost authorship in reports of randomised clinical trials in oncology. European Journal of Cancer. 66. 1–8. 18 indexed citations
10.
Vera-Badillo, Francisco, Martin C. Chang, Alberto Ocaña, et al.. (2015). Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer. Journal of Clinical Pathology. 68(10). 839–843. 6 indexed citations
11.
Ocaña, Alberto, Dolores C. Garcı́a-Olmo, Arnoud J. Templeton, et al.. (2015). Circulating DNA and Survival in Solid Tumors. Cancer Epidemiology Biomarkers & Prevention. 25(2). 399–406. 31 indexed citations
12.
Chang, Martin C., E. del Barco, Francisco Vera-Badillo, et al.. (2015). Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer. PLoS ONE. 10(7). e0132449–e0132449. 40 indexed citations
13.
Al-Mubarak, Mustafa, Francisco Vera-Badillo, Arnoud J. Templeton, et al.. (2015). Impact of Geographic Region on Benefit of Approved Anticancer Drugs Evaluated in International Phase III Clinical Trials. Clinical Oncology. 28(5). 283–291. 4 indexed citations
14.
Templeton, Arnoud J., Olga Ace, Mairéad G. McNamara, et al.. (2014). Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1204–1212. 546 indexed citations breakdown →
15.
Boutron, Isabelle, Douglas G. Altman, Sally Hopewell, et al.. (2014). Impact of Spin in the Abstracts of Articles Reporting Results of Randomized Controlled Trials in the Field of Cancer: The SPIIN Randomized Controlled Trial. Journal of Clinical Oncology. 32(36). 4120–4126. 246 indexed citations
16.
Soest, Robert J. van, Arnoud J. Templeton, Francisco Vera-Badillo, et al.. (2014). Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Annals of Oncology. 26(4). 743–749. 112 indexed citations
17.
Niraula, Saroj, Eitan Amir, Boštjan Šeruga, et al.. (2014). Risk of Incremental Toxicities and Associated Costs of New Anticancer Drugs: a Meta-Analysis. Annals of Oncology. 25. v1–v1. 3 indexed citations
18.
Leibowitz‐Amit, Raya, Nimira Alimohamed, Francisco Vera-Badillo, et al.. (2014). Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone. The Prostate. 74(14). 1462–1464. 4 indexed citations
19.
Vera-Badillo, Francisco, Alberto Ocaña, Arnoud J. Templeton, et al.. (2014). Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis. Breast Cancer Research and Treatment. 146(2). 235–244. 57 indexed citations
20.
Vera-Badillo, Francisco, Esther Conde, & Ignacio Durán. (2012). Chromophobe renal cell carcinoma: A review of an uncommon entity. International Journal of Urology. 19(10). 894–900. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther Bastiaannet Breakdown of academic impact, for papers by Heather Lin Breakdown of academic impact, for papers by Umberto Basso Breakdown of academic impact, for papers by Gloria Broadwater Breakdown of academic impact, for papers by Arnoud J. Templeton Breakdown of academic impact, for papers by Joseph Kim Breakdown of academic impact, for papers by Jyoti D. Patel Breakdown of academic impact, for papers by Ben Tran Breakdown of academic impact, for papers by Kan Yonemori Breakdown of academic impact, for papers by Sylvie Chabaud
Rankless by CCL
2026